About: Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer. The company's first commercial product, KOMZIFTI (ziftomenib), a potent, selective, reversible and oral small molecule menin inhibitor; Darlifarnib, a Phase 1 first-in-human FIT-001 trial which includes multiple cohorts to evaluate darlifarnib in combination with other targeted therapies in large solid tumor indications; and KO-7246, a next-generation menin inhibitor, for use in diabetes and cardiometabolic disorders and additional next-generation menin inhibitors for use in combination with other therapies in solid tumors. The company is headquartered in San Diego, California.
Sector: Healthcare
Industry: Biotechnology
Latest price: $10.56 (-1.49%)
KURA NASDAQ Kura Oncology Inc
Kura Oncology Inc share price
Atividade de preço de KURA
Último preço
$ 10,560
Variação (24h)
-0,16 USD (1,49%)
Volume
1.59M
Volume (média 4 sem.)
-
Abertura
$ 10,70
Variação do dia
$ 10,50 - $ 10,96
Fechamento anterior
$ 10,72
Último negócio
29 Oct, 8:00 pm GMT+0
Atrasado
29 Oct, 8:00 pm GMT+0
KURA price performance
Atrasado
29 Oct, 8:00 pm GMT+0
quote.marketSignals